Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

JoAnn Manson, Dr.P.H., M.D.

Co-Author

This page shows the publications co-authored by JoAnn Manson and Nader Rifai.
Connection Strength

1.435
  1. A prospective study of inflammatory cytokines and diabetes mellitus in a multiethnic cohort of postmenopausal women. Arch Intern Med. 2007 Aug 13-27; 167(15):1676-85.
    View in: PubMed
    Score: 0.094
  2. Hyperproinsulinaemia and risk of Type 2 diabetes mellitus in women. Diabet Med. 2005 Sep; 22(9):1178-84.
    View in: PubMed
    Score: 0.082
  3. E-selectin genotypes and risk of type 2 diabetes in women. Obes Res. 2005 Mar; 13(3):513-8.
    View in: PubMed
    Score: 0.079
  4. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA. 2004 Apr 28; 291(16):1978-86.
    View in: PubMed
    Score: 0.075
  5. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes. 2004 Mar; 53(3):693-700.
    View in: PubMed
    Score: 0.074
  6. Is C-reactive protein specific for vascular disease in women? Ann Intern Med. 2002 Apr 02; 136(7):529-33.
    View in: PubMed
    Score: 0.065
  7. Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation. 1999 Aug 17; 100(7):713-6.
    View in: PubMed
    Score: 0.054
  8. Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic Polymorphisms. Cancer Res. 2016 12 15; 76(24):7160-7167.
    View in: PubMed
    Score: 0.045
  9. Impact of vitamin D supplementation on inflammatory markers in African Americans: results of a four-arm, randomized, placebo-controlled trial. Cancer Prev Res (Phila). 2014 Feb; 7(2):218-25.
    View in: PubMed
    Score: 0.037
  10. Inflammatory plasma markers and pancreatic cancer risk: a prospective study of five U.S. cohorts. Cancer Epidemiol Biomarkers Prev. 2013 May; 22(5):855-61.
    View in: PubMed
    Score: 0.035
  11. A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts. J Natl Cancer Inst. 2013 Jan 16; 105(2):95-103.
    View in: PubMed
    Score: 0.034
  12. Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium. Blood. 2012 Dec 13; 120(25):4929-37.
    View in: PubMed
    Score: 0.034
  13. Plasma adiponectin and the risk of hypertension in white and black postmenopausal women. Clin Chem. 2012 Oct; 58(10):1438-45.
    View in: PubMed
    Score: 0.033
  14. Plasma 25-hydroxyvitamin D and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2012 Jan; 21(1):82-91.
    View in: PubMed
    Score: 0.032
  15. Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in women. Atherosclerosis. 2011 Nov; 219(1):322-9.
    View in: PubMed
    Score: 0.031
  16. Circulating inflammatory and endothelial markers and risk of hypertension in white and black postmenopausal women. Clin Chem. 2011 May; 57(5):729-36.
    View in: PubMed
    Score: 0.030
  17. Association of resistin promoter polymorphisms with plasma resistin levels and type 2 diabetes in women and men. Int J Mol Epidemiol Genet. 2010; 1(3):167-74.
    View in: PubMed
    Score: 0.028
  18. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med. 2009 Sep 17; 361(12):1152-63.
    View in: PubMed
    Score: 0.027
  19. Circulating levels of resistin and risk of type 2 diabetes in men and women: results from two prospective cohorts. Diabetes Care. 2009 Feb; 32(2):329-34.
    View in: PubMed
    Score: 0.026
  20. Inflammation and progressive nephropathy in type 1 diabetes in the diabetes control and complications trial. Diabetes Care. 2008 Dec; 31(12):2338-43.
    View in: PubMed
    Score: 0.025
  21. Plasma dehydroepiandrosterone and risk of myocardial infarction in women. Clin Chem. 2008 Jul; 54(7):1190-6.
    View in: PubMed
    Score: 0.025
  22. Plasma sex steroid hormones and risk of developing type 2 diabetes in women: a prospective study. Diabetologia. 2007 Oct; 50(10):2076-84.
    View in: PubMed
    Score: 0.024
  23. Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: the Women's Health Initiative Observational Study. Diabetes Care. 2007 Jul; 30(7):1747-52.
    View in: PubMed
    Score: 0.023
  24. Circulating levels of endothelial adhesion molecules and risk of diabetes in an ethnically diverse cohort of women. Diabetes. 2007 Jul; 56(7):1898-904.
    View in: PubMed
    Score: 0.023
  25. Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women? J Am Coll Cardiol. 2006 Sep 05; 48(5):973-9.
    View in: PubMed
    Score: 0.022
  26. A prospective study of hemoglobin A1c concentrations and risk of breast cancer in women. Cancer Res. 2006 Mar 01; 66(5):2869-75.
    View in: PubMed
    Score: 0.021
  27. HFE genetic variability, body iron stores, and the risk of type 2 diabetes in U.S. women. Diabetes. 2005 Dec; 54(12):3567-72.
    View in: PubMed
    Score: 0.021
  28. Mediating effects of inflammatory biomarkers on insulin resistance associated with obesity. Obes Res. 2005 Oct; 13(10):1772-83.
    View in: PubMed
    Score: 0.021
  29. Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr. 2005 Jul; 82(1):163-73.
    View in: PubMed
    Score: 0.020
  30. A prospective study of lipoprotein(a) and risk of coronary heart disease among women with type 2 diabetes. Diabetologia. 2005 Aug; 48(8):1469-76.
    View in: PubMed
    Score: 0.020
  31. Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial. Circulation. 2005 May 17; 111(19):2446-53.
    View in: PubMed
    Score: 0.020
  32. Lipoprotein (a) and coronary heart disease among women: beyond a cholesterol carrier? Eur Heart J. 2005 Aug; 26(16):1633-9.
    View in: PubMed
    Score: 0.020
  33. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J Nutr. 2005 Mar; 135(3):562-6.
    View in: PubMed
    Score: 0.020
  34. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med. 2004 Dec 16; 351(25):2599-610.
    View in: PubMed
    Score: 0.020
  35. Joint role of non-HDL cholesterol and glycated haemoglobin in predicting future coronary heart disease events among women with type 2 diabetes. Diabetologia. 2004 Dec; 47(12):2129-36.
    View in: PubMed
    Score: 0.020
  36. Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines. Circulation. 2004 Nov 02; 110(18):2824-30.
    View in: PubMed
    Score: 0.019
  37. Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr. 2004 Oct; 80(4):1029-35.
    View in: PubMed
    Score: 0.019
  38. Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr. 2004 Jul; 134(7):1806-11.
    View in: PubMed
    Score: 0.019
  39. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA. 2004 Feb 11; 291(6):711-7.
    View in: PubMed
    Score: 0.018
  40. A cross-sectional study of alcohol consumption patterns and biologic markers of glycemic control among 459 women. Diabetes Care. 2003 Jul; 26(7):1971-8.
    View in: PubMed
    Score: 0.018
  41. Insulin, proinsulin, proinsulin:insulin ratio, and the risk of developing type 2 diabetes mellitus in women. Am J Med. 2003 Apr 15; 114(6):438-44.
    View in: PubMed
    Score: 0.017
  42. Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol. 2002 Oct 01; 22(10):1668-73.
    View in: PubMed
    Score: 0.017
  43. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. JAMA. 2002 Aug 28; 288(8):980-7.
    View in: PubMed
    Score: 0.017
  44. Relation between markers of systemic vascular inflammation and smoking in women. Am J Cardiol. 2002 May 01; 89(9):1117-9.
    View in: PubMed
    Score: 0.016
  45. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001 Jul 18; 286(3):327-34.
    View in: PubMed
    Score: 0.015
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.